0 XP   0   0   0

J.B.CHEMICALS & PHARMACEUTICALS LTD.
Buy, Hold or Sell?

Should you buy, hold or sell J.B.CHEMICALS & PHARMACEUTICALS LTD.?

I guess you are interested in J.B.CHEMICALS & PHARMACEUTICALS LTD.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse J.B.CHEMICALS & PHARMACEUTICALS LTD.

Let's start. I'm going to help you getting a better view of J.B.CHEMICALS & PHARMACEUTICALS LTD.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is J.B.CHEMICALS & PHARMACEUTICALS LTD. even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how J.B.CHEMICALS & PHARMACEUTICALS LTD. is doing in the market. If the company is worth buying. The latest step is to find out how other investors value J.B.CHEMICALS & PHARMACEUTICALS LTD.. The closing price on 2023-02-08 was INR2,036 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
J.B.CHEMICALS & PHARMACEUTICALS LTD. Daily Candlestick Chart
J.B.CHEMICALS & PHARMACEUTICALS LTD. Daily Candlestick Chart
Summary









1. Valuation of J.B.CHEMICALS & PHARMACEUTICALS LTD.




Current price per share

INR2,035.85

2. Growth of J.B.CHEMICALS & PHARMACEUTICALS LTD.




Is J.B.CHEMICALS & PHARMACEUTICALS LTD. growing?

Current yearPrevious yearGrowGrow %
How rich?$258.7m$219.4m$39.3m15.2%

How much money is J.B.CHEMICALS & PHARMACEUTICALS LTD. making?

Current yearPrevious yearGrowGrow %
Making money$46.6m$54.2m-$7.5m-16.2%
Net Profit Margin15.9%22.3%--

How much money comes from the company's main activities?

3. Financial Health of J.B.CHEMICALS & PHARMACEUTICALS LTD.




Comparing to competitors in the industry




  Industry Rankings ()  



Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of J.B.CHEMICALS & PHARMACEUTICALS LTD..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit J.B.CHEMICALS & PHARMACEUTICALS LTD. earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare J.B.CHEMICALS & PHARMACEUTICALS LTD. to the  industry mean.
  • A Net Profit Margin of 15.9% means that ₹0.16 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of J.B.CHEMICALS & PHARMACEUTICALS LTD.:

  • The MRQ is 15.9%. The company is making a huge profit. +2
  • The TTM is 15.9%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ15.9%TTM15.9%0.0%
TTM15.9%YOY22.3%-6.4%
TTM15.9%5Y16.5%-0.6%
5Y16.5%10Y16.5%0.0%
1.1.2. Return on Assets

Shows how efficient J.B.CHEMICALS & PHARMACEUTICALS LTD. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare J.B.CHEMICALS & PHARMACEUTICALS LTD. to the  industry mean.
  • 14.8% Return on Assets means that J.B.CHEMICALS & PHARMACEUTICALS LTD. generated ₹0.15 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of J.B.CHEMICALS & PHARMACEUTICALS LTD.:

  • The MRQ is 14.8%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 14.8%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ14.8%TTM14.8%0.0%
TTM14.8%YOY20.0%-5.2%
TTM14.8%5Y15.1%-0.4%
5Y15.1%10Y15.1%0.0%
1.1.3. Return on Equity

Shows how efficient J.B.CHEMICALS & PHARMACEUTICALS LTD. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare J.B.CHEMICALS & PHARMACEUTICALS LTD. to the  industry mean.
  • 18.1% Return on Equity means J.B.CHEMICALS & PHARMACEUTICALS LTD. generated ₹0.18 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of J.B.CHEMICALS & PHARMACEUTICALS LTD.:

  • The MRQ is 18.1%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 18.1%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ18.1%TTM18.1%0.0%
TTM18.1%YOY24.8%-6.7%
TTM18.1%5Y18.7%-0.7%
5Y18.7%10Y18.7%0.0%

1.2. Operating Efficiency of J.B.CHEMICALS & PHARMACEUTICALS LTD..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient J.B.CHEMICALS & PHARMACEUTICALS LTD. is operating .

  • Measures how much profit J.B.CHEMICALS & PHARMACEUTICALS LTD. makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare J.B.CHEMICALS & PHARMACEUTICALS LTD. to the  industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of J.B.CHEMICALS & PHARMACEUTICALS LTD.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y8.6%-8.6%
5Y8.6%10Y8.6%0.0%
1.2.2. Operating Ratio

Measures how efficient J.B.CHEMICALS & PHARMACEUTICALS LTD. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 1.16 means that the operating costs are ₹1.16 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of J.B.CHEMICALS & PHARMACEUTICALS LTD.:

  • The MRQ is 1.160. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.160. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.160TTM1.1600.000
TTM1.160YOY1.115+0.046
TTM1.1605Y1.173-0.013
5Y1.17310Y1.1730.000

1.3. Liquidity of J.B.CHEMICALS & PHARMACEUTICALS LTD..

1.3. Liquidity
1.3.1. Current Ratio

Measures if J.B.CHEMICALS & PHARMACEUTICALS LTD. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 3.32 means the company has ₹3.32 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of J.B.CHEMICALS & PHARMACEUTICALS LTD.:

  • The MRQ is 3.322. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.322. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.322TTM3.3220.000
TTM3.322YOY4.497-1.174
TTM3.3225Y3.888-0.566
5Y3.88810Y3.8880.000
1.3.2. Quick Ratio

Measures if J.B.CHEMICALS & PHARMACEUTICALS LTD. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare J.B.CHEMICALS & PHARMACEUTICALS LTD. to the  industry mean.
  • A Quick Ratio of 1.45 means the company can pay off ₹1.45 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of J.B.CHEMICALS & PHARMACEUTICALS LTD.:

  • The MRQ is 1.448. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.448. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ1.448TTM1.4480.000
TTM1.448YOY3.053-1.604
TTM1.4485Y2.379-0.930
5Y2.37910Y2.3790.000

1.4. Solvency of J.B.CHEMICALS & PHARMACEUTICALS LTD..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of J.B.CHEMICALS & PHARMACEUTICALS LTD. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare J.B.CHEMICALS & PHARMACEUTICALS LTD. to industry mean.
  • A Debt to Asset Ratio of 0.18 means that J.B.CHEMICALS & PHARMACEUTICALS LTD. assets are financed with 18.0% credit (debt) and the remaining percentage (100% - 18.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of J.B.CHEMICALS & PHARMACEUTICALS LTD.:

  • The MRQ is 0.180. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.180. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.180TTM0.1800.000
TTM0.180YOY0.190-0.010
TTM0.1805Y0.187-0.007
5Y0.18710Y0.1870.000
1.4.2. Debt to Equity Ratio

Measures if J.B.CHEMICALS & PHARMACEUTICALS LTD. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare J.B.CHEMICALS & PHARMACEUTICALS LTD. to the  industry mean.
  • A Debt to Equity ratio of 22.0% means that company has ₹0.22 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of J.B.CHEMICALS & PHARMACEUTICALS LTD.:

  • The MRQ is 0.220. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.220. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.220TTM0.2200.000
TTM0.220YOY0.235-0.015
TTM0.2205Y0.231-0.011
5Y0.23110Y0.2310.000

2. Market Valuation of J.B.CHEMICALS & PHARMACEUTICALS LTD.

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings J.B.CHEMICALS & PHARMACEUTICALS LTD. generates.

  • Above 15 is considered overpriced but always compare J.B.CHEMICALS & PHARMACEUTICALS LTD. to the  industry mean.
  • A PE ratio of 31.59 means the investor is paying ₹31.59 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of J.B.CHEMICALS & PHARMACEUTICALS LTD.:

  • The EOD is 40.828. Good. +1
  • The MRQ is 31.590. Good. +1
  • The TTM is 31.590. Good. +1
Trends
Current periodCompared to+/- 
EOD40.828MRQ31.590+9.238
MRQ31.590TTM31.5900.000
TTM31.590YOY21.627+9.963
TTM31.5905Y20.643+10.947
5Y20.64310Y20.6430.000
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of J.B.CHEMICALS & PHARMACEUTICALS LTD..

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of J.B.CHEMICALS & PHARMACEUTICALS LTD.:

  • The MRQ is 36.722. Seems overpriced? -1
  • The TTM is 36.722. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ36.722TTM36.7220.000
TTM36.722YOY13.134+23.588
TTM36.7225Y19.916+16.806
5Y19.91610Y19.9160.000

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of J.B.CHEMICALS & PHARMACEUTICALS LTD. is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of 5.69 means the investor is paying ₹5.69 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of J.B.CHEMICALS & PHARMACEUTICALS LTD.:

  • The EOD is 7.357. Seems overpriced? -1
  • The MRQ is 5.692. Seems overpriced? -1
  • The TTM is 5.692. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD7.357MRQ5.692+1.665
MRQ5.692TTM5.6920.000
TTM5.692YOY5.342+0.350
TTM5.6925Y3.928+1.764
5Y3.92810Y3.9280.000
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of J.B.CHEMICALS & PHARMACEUTICALS LTD. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--42.07742.0770%48.580-13%69.182-39%69.182-39%
Book Value Growth--1.1791.1790%1.261-6%1.137+4%1.137+4%
Book Value Per Share--276.728276.7280%234.651+18%220.567+25%220.567+25%
Book Value Per Share Growth--1.1791.1790%1.261-6%1.149+3%1.149+3%
Current Ratio--3.3223.3220%4.497-26%3.888-15%3.888-15%
Debt To Asset Ratio--0.1800.1800%0.190-5%0.187-4%0.187-4%
Debt To Equity Ratio--0.2200.2200%0.235-6%0.231-5%0.231-5%
Dividend Per Share--16.50616.5060%9.477+74%11.705+41%11.705+41%
Dividend Per Share Growth--1.7421.7420%0.519+235%3.100-44%3.100-44%
Eps--49.86449.8640%57.965-14%41.786+19%41.786+19%
Eps Growth--0.8600.8600%1.647-48%1.322-35%1.322-35%
Free Cash Flow Per Share---69.441-69.4410%34.550-301%2.334-3075%2.334-3075%
Free Cash Flow Per Share Growth---2.010-2.0100%1.319-252%0.254-892%0.254-892%
Free Cash Flow To Equity Per Share---69.441-69.4410%34.550-301%-12.418-82%-12.418-82%
Free Cash Flow To Equity Per Share Growth---2.010-2.0100%4.576-144%-1.737-14%-1.737-14%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin--0.1590.1590%0.223-29%0.165-3%0.165-3%
Operating Margin----0%-0%0.086-100%0.086-100%
Operating Ratio--1.1601.1600%1.115+4%1.173-1%1.173-1%
Pb Ratio7.357+23%5.6925.6920%5.342+7%3.928+45%3.928+45%
Pe Ratio40.828+23%31.59031.5900%21.627+46%20.643+53%20.643+53%
Peg Ratio--36.72236.7220%13.134+180%19.916+84%19.916+84%
Price Per Share2035.850+23%1575.2001575.2000%1253.600+26%924.188+70%924.188+70%
Price To Total Gains Ratio34.751+23%26.88826.8880%21.592+25%19.118+41%19.118+41%
Profit Growth--0.8600.8600%1.647-48%1.304-34%1.304-34%
Quick Ratio--1.4481.4480%3.053-53%2.379-39%2.379-39%
Return On Assets--0.1480.1480%0.200-26%0.151-2%0.151-2%
Return On Equity--0.1810.1810%0.248-27%0.187-3%0.187-3%
Revenue Growth--1.2091.2090%1.151+5%1.147+5%1.147+5%
Total Gains Per Share--58.58458.5840%58.057+1%80.887-28%80.887-28%
Total Gains Per Share Growth--1.0091.0090%2.978-66%1.364-26%1.364-26%
Usd Book Value--258772160.900258772160.9000%219425017.900+18%207907003.700+24%207907003.700+24%
Usd Book Value Change Per Share--0.5090.5090%0.588-13%0.837-39%0.837-39%
Usd Book Value Per Share--3.3483.3480%2.839+18%2.669+25%2.669+25%
Usd Dividend Per Share--0.2000.2000%0.115+74%0.142+41%0.142+41%
Usd Eps--0.6030.6030%0.701-14%0.506+19%0.506+19%
Usd Free Cash Flow---64935218.700-64935218.7000%32308439.900-301%2344178.375-2870%2344178.375-2870%
Usd Free Cash Flow Per Share---0.840-0.8400%0.418-301%0.028-3075%0.028-3075%
Usd Free Cash Flow To Equity Per Share---0.840-0.8400%0.418-301%-0.150-82%-0.150-82%
Usd Price Per Share24.634+23%19.06019.0600%15.169+26%11.183+70%11.183+70%
Usd Profit--46628245.40046628245.4000%54203595.600-14%39289740.600+19%39289740.600+19%
Usd Revenue--293333499.800293333499.8000%242707523.300+21%235436642.375+25%235436642.375+25%
Usd Total Gains Per Share--0.7090.7090%0.702+1%0.979-28%0.979-28%
 EOD+2 -3MRQTTM+0 -0YOY+14 -275Y+17 -2510Y+17 -25

3.2. Fundamental Score

Let's check the fundamental score of J.B.CHEMICALS & PHARMACEUTICALS LTD. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1540.828
Price to Book Ratio (EOD)Between0-17.357
Net Profit Margin (MRQ)Greater than00.159
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.448
Current Ratio (MRQ)Greater than13.322
Debt to Asset Ratio (MRQ)Less than10.180
Debt to Equity Ratio (MRQ)Less than10.220
Return on Equity (MRQ)Greater than0.150.181
Return on Assets (MRQ)Greater than0.050.148
Total7/10 (70.0%)

3.3. Technical Score

Let's check the technical score of J.B.CHEMICALS & PHARMACEUTICALS LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5056.537
Ma 20Greater thanMa 501,994.970
Ma 50Greater thanMa 1001,996.357
Ma 100Greater thanMa 2001,981.572
OpenGreater thanClose1,950.050
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2022-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets26,074,022
Total Liabilities4,687,893
Total Stockholder Equity21,341,230
 As reported
Total Liabilities 4,687,893
Total Stockholder Equity+ 21,341,230
Total Assets = 26,074,022

Assets

Total Assets26,074,022
Total Current Assets12,748,550
Long-term Assets12,748,550
Total Current Assets
Cash And Cash Equivalents 565,441
Short-term Investments 1,062
Net Receivables 5,556,868
Inventory 4,099,611
Other Current Assets 1,843,592
Total Current Assets  (as reported)12,748,550
Total Current Assets  (calculated)12,066,574
+/- 681,976
Long-term Assets
Goodwill 574,592
Intangible Assets 6,713,944
Long-term Assets  (as reported)13,325,472
Long-term Assets  (calculated)7,288,536
+/- 6,036,936

Liabilities & Shareholders' Equity

Total Current Liabilities3,837,156
Long-term Liabilities850,737
Total Stockholder Equity21,341,230
Total Current Liabilities
Short Long Term Debt 263,150
Accounts payable 2,244,797
Other Current Liabilities 88,201
Total Current Liabilities  (as reported)3,837,156
Total Current Liabilities  (calculated)2,596,148
+/- 1,241,008
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt282,438
Long-term Liabilities Other 31,664
Long-term Liabilities  (as reported)850,737
Long-term Liabilities  (calculated)314,102
+/- 536,635
Total Stockholder Equity
Retained Earnings 18,427,069
Total Stockholder Equity (as reported)21,341,230
Total Stockholder Equity (calculated)18,427,069
+/- 2,914,161
Other
Capital Stock154,564
Common Stock Shares Outstanding 77,282
Net Invested Capital 21,604,380
Net Working Capital 8,911,394



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2022-03-312021-03-312020-03-312019-03-312018-03-312017-03-31
> Total Assets 
0
0
17,910,005
18,135,611
22,381,152
26,074,022
26,074,02222,381,15218,135,61117,910,00500
   > Total Current Assets 
7,948,902
10,472,125
10,511,522
10,727,284
15,526,024
12,748,550
12,748,55015,526,02410,727,28410,511,52210,472,1257,948,902
       Cash And Cash Equivalents 
0
0
353,968
290,079
286,855
565,441
565,441286,855290,079353,96800
       Short-term Investments 
0
0
3,606,499
3,338,126
6,649,748
1,062
1,0626,649,7483,338,1263,606,49900
       Net Receivables 
2,759,122
3,073,200
3,248,376
3,565,085
3,890,191
5,556,868
5,556,8683,890,1913,565,0853,248,3763,073,2002,759,122
       Inventory 
2,001,686
2,137,314
2,437,577
2,746,697
3,474,468
4,099,611
4,099,6113,474,4682,746,6972,437,5772,137,3142,001,686
       Other Current Assets 
753,380
1,065,465
756,803
671,326
928,228
1,843,592
1,843,592928,228671,326756,8031,065,465753,380
   > Long-term Assets 
0
0
7,414,252
7,408,327
6,855,128
13,325,472
13,325,4726,855,1287,408,3277,414,25200
       Property Plant Equipment 
6,010,328
5,811,134
5,595,066
5,841,967
0
0
005,841,9675,595,0665,811,1346,010,328
       Goodwill 
0
0
531,400
531,400
574,592
574,592
574,592574,592531,400531,40000
       Intangible Assets 
0
0
233,775
300,924
321,052
6,713,944
6,713,944321,052300,924233,77500
       Long-term Assets Other 
0
0
0
1
10,689
-90,321
-90,32110,6891000
> Total Liabilities 
0
0
3,080,748
3,755,708
4,246,853
4,687,893
4,687,8934,246,8533,755,7083,080,74800
   > Total Current Liabilities 
2,812,084
2,751,153
2,441,838
3,128,460
3,452,737
3,837,156
3,837,1563,452,7373,128,4602,441,8382,751,1532,812,084
       Short Long Term Debt 
0
0
257,977
320,361
326,446
263,150
263,150326,446320,361257,97700
       Accounts payable 
989,771
1,103,950
1,173,746
1,237,925
1,869,234
2,244,797
2,244,7971,869,2341,237,9251,173,7461,103,950989,771
       Other Current Liabilities 
1,230,209
1,199,025
970,343
1,449,283
99,404
88,201
88,20199,4041,449,283970,3431,199,0251,230,209
   > Long-term Liabilities 
0
0
648,391
627,248
794,116
850,737
850,737794,116627,248648,39100
       Capital Lease Obligations Min Short Term Debt
0
0
0
61,822
123,433
282,438
282,438123,43361,822000
       Long-term Liabilities Other 
0
0
22,029
59,684
49,322
31,664
31,66449,32259,68422,02900
       Deferred Long Term Liability 
0
0
1,576
0
0
0
0001,57600
> Total Stockholder Equity
0
0
14,801,224
14,354,893
18,097,248
21,341,230
21,341,23018,097,24814,354,89314,801,22400
   Common Stock
169,640
167,140
160,473
154,564
0
0
00154,564160,473167,140169,640
   Retained Earnings Total Equity000000
   Accumulated Other Comprehensive Income 000000
   Capital Surplus 000000
   Treasury Stock000000
   Other Stockholders Equity 
-31,506
24,879
-5,698
-143,077
0
0
00-143,077-5,69824,879-31,506



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2022-03-31)

Gross Profit (+$)
totalRevenue24,242,438
Cost of Revenue-8,633,745
Gross Profit15,608,69315,608,693
 
Operating Income (+$)
Gross Profit15,608,693
Operating Expense-19,496,469
Operating Income4,745,969-3,887,776
 
Operating Expense (+$)
Research Development-
Selling General Administrative3,160,995
Selling And Marketing Expenses-
Operating Expense19,496,4693,160,995
 
Net Interest Income (+$)
Interest Income9,343
Interest Expense-47,853
Net Interest Income-41,862-38,510
 
Pretax Income (+$)
Operating Income4,745,969
Net Interest Income-41,862
Other Non-Operating Income Expenses-
Income Before Tax (EBT)5,049,0204,745,969
EBIT - interestExpense = -47,853
3,853,574
3,901,427
Interest Expense47,853
Earnings Before Interest and Taxes (ebit)-5,096,873
Earnings Before Interest and Taxes (ebitda)5,823,472
 
After tax Income (+$)
Income Before Tax5,049,020
Tax Provision-1,188,633
Net Income From Continuing Ops3,860,3873,860,387
Net Income3,853,574
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-41,862
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
UNICHEMLAB.BSE
5 minutes ago

I found you a Death Cross on the daily chart of UNICHEMLAB.BSE.

UNICHEMLAB.BSE Daily Candlestick Chart
TRIVENIENT.BSE
7 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of TRIVENIENT.BSE.

TRIVENIENT.BSE Daily Candlestick Chart
TINNARUBR.BSE
10 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of TINNARUBR.BSE.

TINNARUBR.BSE Daily Candlestick Chart
WAT.AU
12 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of WAT.AU.

WAT.AU Daily Candlestick Chart
SYMBIOX.BSE
13 minutes ago

I found you a Death Cross on the daily chart of SYMBIOX.BSE.

SYMBIOX.BSE Daily Candlestick Chart
SUPERBAK.BSE
14 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of SUPERBAK.BSE.

SUPERBAK.BSE Daily Candlestick Chart
ABVL.BSE
15 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of ABVL.BSE.

ABVL.BSE Daily Candlestick Chart
RAVALSUGAR.BSE
15 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of RAVALSUGAR.BSE.

RAVALSUGAR.BSE Daily Candlestick Chart
PAYTM*.BSE
16 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of PAYTM*.BSE.

PAYTM*.BSE Daily Candlestick Chart
GARGI.BSE
16 minutes ago

I found you a RSI Bullish Hidden Divergence on the daily chart of GARGI.BSE.

GARGI.BSE Daily Candlestick Chart
VRFILMS.BSE
17 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of VRFILMS.BSE.

VRFILMS.BSE Daily Candlestick Chart
IFINSER.BSE
17 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of IFINSER.BSE.

IFINSER.BSE Daily Candlestick Chart
MILESTONE.BSE
17 minutes ago

I found you a RSI Bullish Reversal Divergence on the daily chart of MILESTONE.BSE.

MILESTONE.BSE Daily Candlestick Chart
SRDAPRT.BSE
18 minutes ago

I found you a RSI Bearish Hidden Divergence on the daily chart of SRDAPRT.BSE.

SRDAPRT.BSE Daily Candlestick Chart
SONATSOFTW.BSE
18 minutes ago

I found you a Bearish Three Line Strike Candle Pattern on the daily chart of SONATSOFTW.BSE.

SONATSOFTW.BSE Daily Candlestick Chart
SHREEGANES.BSE
20 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SHREEGANES.BSE.

SHREEGANES.BSE Daily Candlestick Chart
SCOOBEEDAY.BSE
21 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SCOOBEEDAY.BSE.

SCOOBEEDAY.BSE Daily Candlestick Chart
SCHAEFFLER.BSE
21 minutes ago

I found you a Death Cross on the daily chart of SCHAEFFLER.BSE.

SCHAEFFLER.BSE Daily Candlestick Chart
SARTHAKIND.BSE
21 minutes ago

I found you a RSI Bullish Reversal Divergence on the daily chart of SARTHAKIND.BSE.

SARTHAKIND.BSE Daily Candlestick Chart
SARLAPOLY.BSE
22 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SARLAPOLY.BSE.

SARLAPOLY.BSE Daily Candlestick Chart
SADHNA.BSE
22 minutes ago

I found you a RSI Bearish Hidden Divergence on the daily chart of SADHNA.BSE.

SADHNA.BSE Daily Candlestick Chart
SADBHIN.BSE
23 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SADBHIN.BSE.

SADBHIN.BSE Daily Candlestick Chart
RUCHIRA.BSE
23 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of RUCHIRA.BSE.

RUCHIRA.BSE Daily Candlestick Chart
RTFL.BSE
23 minutes ago

I found you a Bearish Engulfing Candle Pattern on the daily chart of RTFL.BSE.

RTFL.BSE Daily Candlestick Chart